Compare CCD & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCD | CRMD |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.0M | 590.7M |
| IPO Year | 2014 | 2009 |
| Metric | CCD | CRMD |
|---|---|---|
| Price | $19.35 | $4.76 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.80 |
| AVG Volume (30 Days) | 82.5K | ★ 2.0M |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | ★ 10.61% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $8.05 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.45 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $19.28 | $4.72 |
| 52 Week High | $26.99 | $13.02 |
| Indicator | CCD | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.45 | 24.97 |
| Support Level | N/A | N/A |
| Resistance Level | $25.90 | $8.79 |
| Average True Range (ATR) | 0.65 | 0.53 |
| MACD | -0.08 | -0.14 |
| Stochastic Oscillator | 0.92 | 1.10 |
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.